α-Synuclein immunoreactivity is present in axonal swellings in neuroaxonal dystrophy and acute traumatic brain injury

Journal of Neuropathology and Experimental Neurology

Volumn 58, Issue 12, 1999, Pages 1263-1268

  Newell, Kathy L ^a,b   Boyer, Philip ^a   Gomez Tortosa, Estrella ^a   Hobbs, Wendy ^a   Hedley Whyte, E Tessa ^a   Vonsattel, Jean Paul ^a   Hyman, Bradley T ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Axonal spheroids; Axonal swellings; Diffuse axonal injury; Hallervorden Spatz syndrome; Lewy body; Neuroaxonal dystrophy; synuclein

Indexed keywords

ALPHA SYNUCLEIN;

ADOLESCENT; ADULT; ARTICLE; BRAIN INJURY; CELL INCLUSION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; FEMALE; HALLERVORDEN SPATZ DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEWY BODY; MALE; NERVE FIBER DEGENERATION; NEURITE; NEUROAXONAL DYSTROPHY; PARKINSON DISEASE; PRIORITY JOURNAL; SPHEROID CELL;

EID: 0032786711     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199912000-00007     Document Type: Article

References (35)

1. Takeda A, Mallory M, Sundsmo M, Honer W, Hansen L, Masliah E. Abnormal accumulation of NACP/α-synuclein in neurodegenerative disorders. Am J Pathol 1998; 152:367-72
2. Spillantini MG, Schmidt ML, Lee V M-Y, Trojanowski JQ, Jakes R, Goedert M. α-Synuclein in Lewy bodies. Nature 1997;388: 839-40
3. Irizarry MC, Growdon W, Gomez-Isla T, et al. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain α-synuclein immunoreactivity. J Neuropathol Exp Neurol 1998;57:334-37
4. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 1998;95:6469-73
5. Baba M, Nakajo S, Tu P-H, et al. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 1998;152:879-84
6. Tu PH, Galvin JE, Baba M, et al. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein. Ann Neurol 1998;44:415-22
7. Lippa CF, Fujiwara H, Mann DMA, et al. Lewy bodies contain altered α-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol 1998;153:1365-70
8. Arawaka S, Saito Y, Murayama S, Mori H. Lewy body in neurodegeneration with brain iron accumulation type I is immunoreactive for α-synuclein. Neurology 1998;51:887-89
9. Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H. α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 1998;249:180-82
10. Wakabayashi K, Hayashi S, Kakita A, et al. Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. Acta Neuropathol 1998;96:445-52
11. Mezey E, Dehejia A, Harta G, Papp MI, Polymeropoulos MH, Brownstein MJ. Alpha synuclein in neurodegenerative disorders: Murderer or accomplice? Nat Med 1998;4:755-57
12. Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M. Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett 1998;251:205-8
13. Seitelberger F. Neuroaxonal dystrophy: Its relation to aging and neurological diseases. In: Vinken PJ, Bruyn GW, Klawans HL, eds. Handbook of clinical neurology: Extrapyramidal disorders. Amsterdam: Elsevier Science, 1986;Vol 5(49):391-415
14. Lowe J, Lennox G, Leigh PN. Disorders of movement and system degenerations. In: Graham DI, Lantos PL, eds. Greenfield's neuropathology, 6th edition. London: Edward Arnold, 1997;Vol II: 336-39
15. Seitelberger F. Neuropathological conditions related to neuroaxonal dystrophy. Acta Neuropathol 1971;Suppl 5:17-29
16. Hedley-Whyte ET, Gilles FH, Uzman BG. Infantile neuroaxonal dystrophy. A disease characterized by altered terminal axons and synaptic endings. Neurology 1968;18:891-906
17. Dooling EC, Schoene WC, Richardson EP, Jr. Hallervorden-Spatz syndrome. Arch Neurol 1974;30:70-83
18. Taylor TD, Litt M, Kramer R et al. Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3-p13. Nat Genet 1996;14:479-81
19. Rozdilsky B, Bolton CF, Takeda M. Neuroaxonal dystrophy. A case of delayed onset and protracted course. Acta Neuropathol 1971;17: 331-40
20. Defendini R, Markesbery WR, Mastri AR, Duffy PE. Hallervorden-Spatz disease and infantile neuroaxonal dystrophy. Ultrastructural observations, anatomical pathology, and nosology. J Neurol Sci 1973;20:7-23
21. Park BE, Netsky MG, Betsill WL. Pathogenesis of pigment and spheroid formation in Hallervorden-Spatz syndrome and related disorders. Neurology 1975;25:1172-78
22. Williamson K, Sima AAF, Curry B, Ludwin SK. Neuroaxonal dystrophy in young adults: a clinicopathological study of two unrelated cases. Ann Neurol 1982;11:335-43
23. Antoine JC, Tommasi M, Chalumeau A, Jouvet-Telinge A, Bourrat Ch. Maladie de Hallervorden-Spatz avec corps de Lewy. Rev Neurol 1985;141:806-9
24. Alberca R, Rafel E, Chinchon I, Vadillo J, Navarro A. Late onset parkinsonian syndrome in Hallervorden-Spatz disease. J Neurol Neurosurg Psychiatry 1987;50:1665-68
25. Eidelberg D, Sotrel A, Joachim C, et al. Adult onset Hallervorden-Spatz disease with neurofibrillary pathology. A discrete clinicopathological entity. Brain 1987;110:993-1013
26. Gaytan-Garcia S, Kaufmann JCE, Young GB. Adult onset Hallervorden-Spatz syndrome or Seitelberger's disease with late onset: variants of the same entity? A clinico-pathological study. Clin Neuropathol 1990;9:136-42
27. Sugiyama H, Hainfellner JA, Schmid-Siegel B, Budka H. Neuroaxonal dystrophy combined with diffuse Lewy body disease in a young adult. Clin Neuropathol 1993;12:147-52
28. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-47
29. Cochran E, Bacci B, Chen Y, Patton A, Gambetti P, Autilio-Gambetti L. Amyloid precursor protein and ubiquitin immunoreactivity in dystrophic axons is not unique to Alzheimer's disease. Am J Pathol 1991;139:485-89
30. Ohgami T, Kitamoto T, Tateishi J. Alzheimer's amyloid precursor protein accumulates within axonal swellings in human brain lesions. Neurosci Lett 1992;136:75-78
31. Gultekin SH, Smith TW. Diffuse axonal injury in craniocerebral trauma. A comparative histologic and immunohistochemical study. Arch Pathol Lab Med 1994;118:168-71
32. Sherriff FE, Bridges LR, Sivaloganathan S. Early detection of axonal injury after human head trauma using immunocytochemistry for β-amyloid precursor protein. Acta Neuropathol 1994;87:55-62
33. Head and spinal injuries. In: Ellison D, Love S, Chimelli L, Harding B, Lowe J, Roberts GW, Vinters HV, eds. Neuropathology. London: Mosby, 1998;11.9-11.13
34. Gomez-Tortosa E, Newell K, Irizarry MC, Albert M, Growdon JH, Hyman BT. Clinical and quantitative pathological correlates of dementia with Lewy bodies. Neurology (in press)
35. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 1996;47:1113-24